Teva Pharmaceuticals MExico
Projections for Growth
Generic drugs produced at Teva ’ s two facilities in Mexico , and their commercialization brought more than $ 100 million in revenue . Starting on 2015 , the company is seeking a 10 percent yearly growth , mainly from new product manufacturing in their Lerma plant , near Toluca , capital of the State of Mexico .
To be continued in the next edition of Healthcare Global …
“ Sales come through the public sector -bidding and institutional sales , mostly- , from private healthcare , including sales from innovative products ( Copaxone ®
LATIN AMERICA
Company Information
Name
Teva Pharmaceuticals Mexico
Industry
Healthcare - Pharmaceuticals
headquarters
Naucalpan de Juarez , Estado de Mexico , Mexico
founded
2004
employees
600 +
revenue
USD $ 100 million
website www . tevamexico . com and Azilect ®), as well as from OTC products ” www . tevamexico . com 93